Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fanca deficiency is associated with alterations in osteoclastogenesis that are rescued by TNFα. | Cell Biosci | 2023 | 37355617 | PubTator, text mining | PubMed |
| The clinical utility of rapid exome sequencing in a consanguineous population. | Genome Med | 2023 | 37344829 | PubTator, text mining | PubMed |
| Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer. | Sci Rep | 2023 | 37336919 | PubTator, text mining | PubMed |
| Combination of C-reactive protein/albumin ratio and time to castration resistance enhances prediction of prognosis for patients with metastatic castration-resistant prostate cancer. | Front Oncol | 2023 | 37333829 | PubTator, text mining | PubMed |
| An acquired BMF with FANCL gene heterozygous mutation: Case report. | Medicine (Baltimore) | 2023 | 37327301 | PubTator, text mining | PubMed |
| Structural and biochemical characterisation of Co2+-binding sites on serum albumins and their interplay with fatty acids. | Chem Sci | 2023 | 37325156 | PubTator, text mining | PubMed |
| FANCI is Associated with Poor Prognosis and Immune Infiltration in Liver Hepatocellular Carcinoma. | Int J Med Sci | 2023 | 37324186 | PubTator, text mining | PubMed |
| Venetoclax and Azacitidine in the Treatment of NPM1-Mutated Donor Cell-Derived Leukemia in a Patient With Fanconi Anemia: Case Report and Literature Review. | JCO Precis Oncol | 2023 | 37315262 | PubTator, text mining | PubMed |
| Fanconi Anemia: A Rare Genetic Disorder. | Cureus | 2023 | 37303314 | PubTator, text mining | PubMed |
| The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer-A GEICO Study. | Cancers (Basel) | 2023 | 37296992 | PubTator, text mining | PubMed |
| Molecular Targeted Therapies in Metastatic Prostate Cancer: Recent Advances and Future Challenges. | Cancers (Basel) | 2023 | 37296848 | PubTator, text mining | PubMed |
| Testis cell pyroptosis mediated by CASP1 and CASP4: possible sertoli cell-only syndrome pathogenesis. | Reprod Biol Endocrinol | 2023 | 37296437 | PubTator, text mining | PubMed |
| Correcting the aberrant Fanconi anemia transcriptional program by gene therapy. | Haematologica | 2023 | 37288500 | PubTator, text mining | PubMed |
| Genetic profiling of circulating cell-free DNA from cerebrospinal fluid and paired plasma in ALK-positive lung cancer with brain metastases. | Thorac Cancer | 2023 | 37287428 | PubTator, text mining | PubMed |
| Mismatch repair gene germline mutations in patients with prostate cancer. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2023 | 37283096 | PubTator, text mining | PubMed |
| The utility of multiple genomic technologies for interpretation of modern next generation sequencing: A novel case of three FANCA gene variants resulting in autosomal recessive Fanconi anaemia. | Blood Cells Mol Dis | 2023 | 37276838 | PubTator, text mining | PubMed |
| Telomere biology: from disorders to hematological diseases. | Front Oncol | 2023 | 37274248 | PubTator, text mining | PubMed |
| Multiple genetic variants involved in both autoimmunity and autoinflammation detected in Chinese patients with sporadic Meniere's disease: a preliminary study. | Front Neurol | 2023 | 37273692 | PubTator, text mining | PubMed |
| Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types. | Sci Rep | 2023 | 37264024 | PubTator, text mining | PubMed |
| Acquired DNA damage repairs deficiency-driven immune evolution and involved immune factors of local versus distant metastases in non-small cell lung cancer. | Oncoimmunology | 2023 | 37261085 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=22